The average tumor volume of the mice that were treated with Mcl-1 siRNA alone at the end of the experiment was 875 ± 134.3 mm3, which was significantly lower than that of control and vemurafenib treated mice (Fig. 6A). This evidence concerns the gene MCL1 and neoplasm.